PlantX Launches Baby Products Vertical with Else Nutrition PlantX joins estimated USD $12.1 billion North American baby formula
January 05 2021 - 3:06PM
InvestorsHub NewsWire
PlantX
Launches Baby Products Vertical with Else Nutrition
PlantX
joins estimated USD $12.1 billion North American baby formula and
toddler formula industry1
![](https://investorshub.advfn.com/uimage/uploads/2021/1/5/vkbglScreen_Shot_2021-01-05_at_3.23.29_PM.png)
VANCOUVER,
British Columbia, CANADA -- January 5,
2021 -- InvestorsHub
NewsWire -- PlantX Life Inc. (the "Company"
or "PlantX")
(CSE:
VEGA) (Frankfurt: WNT1) (OTCQB:
PLTXF) is pleased to announce
that the Company's U.S. ecommerce
platform
www.PlantX.com will begin featuring baby
formula products from Else
Nutrition
Holdings Inc. ("Else
Nutrition") (TSXV:
BABY) (OTCQX: BABYF) (FSE: 0YL).
The addition
of plant-based baby formula allows PlantX to further expand its
category verticals. Else Nutrition's baby formula will be
the first product available to order in the new baby products
section of the
Company's U.S. ecommerce
platform,
https://plantx.com/brand/else-nutrition/.
"We are thrilled
to be listed on the PlantX platform. Joining this innovative online
platform solely dedicated to plant-based companies aligns perfectly
with our mission to bring clean label and sustainable
plant-based options for parents to
nourish their infants," said Hamutal Yitzhak,
CEO and
co-founder of Else
Nutrition. "We are proud to be part of
a platform of like-minded, purpose-driven
brands and raising awareness for plant-based nutrition and its
benefits to a growing segment of consumers. This will help bolster
Else Nutrition's presence in both North
America and Europe."
1
https://www.imarcgroup.com/north-america-baby-food-infant-formula-market#:~:text=The%20North%20America%20Baby%20Food,US%24%2012.1%20Billion%20in%202019
The North
America baby food and infant formula market continues to grow as
new products are introduced, such as those announced by Else
Nutrition and PlantX. According to IMARC Group,
the market is expected to reach a value of US$16.6 billion by
2025 at a compound annual
growth rate of 5.5% over the
next five years.
Else Nutrition
was founded to better serve children with allergies, intolerances
and dietary restrictions as well as families who seek plant-based
clean nutrition for their babies and toddlers. The plant-based baby
formula contains natural and organic ingredients to create a
sustainable upbringing for children that is free from dairy, GMOs,
corn syrup and gluten. Intended for babies 12 months and older, the
formula is made with primarily almonds, buckwheat and tapioca in
addition to 20 vitamins and minerals to support growth and
development at an early age.
"Launching the
new baby products section of PlantX.com with Else Nutrition is
very exciting for
us," said Julia Frank, PlantX
CEO. "We've seen the success of the
baby formula market and having it in our plant-based umbrella only adds to
the potential in this space."
PlantX
continues to advance its plans to open its first brick and mortar
locations in San Diego, California, Squamish, British Columbia and
Tel Aviv, Israel, with plans of future franchising and expansion
across the globe. PlantX will also continue to expand its
e-commerce capabilities around the world with new and exciting
partnerships, acquisitions and verticals in the plant-based
industry. As a partner of PlantX, Else Nutrition will be able to
expand its distribution
through the
Company's
online distribution and future physical locations.
PlantX will be
streaming its weekly live vodcast with PlantX founder Sean
Dollinger interviewing Else Nutrition CEO, Hamutal
Yitzhak. Ms Yitzhak will discuss the Else Nutrition partnership
and the
importance of plant-based nutrition. Watch the stream Saturday,
Jan. 9, at 10:30 a.m. PST /
1:30 p.m.
EST from the Company's YouTube
channel available at
https://youtu.be/penSyIP2j14.
About
PlantX Life Inc.
As the digital face of the
plant-based community,
PlantX's
platform is the one-stop-shop for everything
plant-based. With its fast growing category verticals, the Company
offers customers across North America more than 10,000 plant-based
products. In addition to offering meal and indoor plant deliveries,
the Company currently has plans underway to expand its product
lines to include cosmetics, clothing, and its own water
brand — but the business is not
limited to an e-commerce platform. The Company uses its digital
platform to build a community of like-minded consumers, and most
importantly, provide education. Its successful enterprise is being
built and fortified on partnerships with top nutritionists, chefs,
and brands. The Company eliminates the barriers to entry for anyone
interested in living a plant-based lifestyle, and thriving in a
longer, healthier, and happier life.
About
Else Nutrition Holdings Inc.
Else Nutrition
GH Ltd. is an Israel-based food and nutrition company focused on
developing innovative, clean and plant-based food and nutrition
products for infants, toddlers, children, and
adults. Its revolutionary,
plant-based, non-soy, formula is a clean-ingredient alternative to
dairy-based formula. Else Nutrition (formerly INDI) won the "2017
Best Health and Diet Solutions" award at the Global Food Innovation
Summit in Milan. Else Toddler Nutrition was a #1 Best Seller on
Amazon in the Baby/Toddler Formula Category in 2020. The holding
company, Else Nutrition Holdings Inc., is a publicly traded
company, listed as TSX Venture Exchange under the trading symbol
BABY and is quoted on the US OTC Markets QX board under the trading
symbol BABYF and on the Frankfurt Exchange under the symbol 0YL.
Else's Executives includes leaders hailing from leading infant
nutrition companies. Many of Else advisory board members had past
executive roles in companies such as Mead Johnson, Abbott
Nutrition, Plum Organics and leading infant nutrition Societies,
and some of them currently serve in different roles in leading
medical centers and academic institutes such as Boston Children's
Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv
University, Schneider Children's Medical Center of Israel,
Children's Hospital of Colorado, Rambam Medical Center and
Technion, Israel and University Hospital Brussels,
Belgium.
CONTACT
INFORMATION
For additional information,
please contact:
Alexandra Hoffman
Chief Marketing
Officer
(323)
536-7973
alex@PlantX.com
The Company website
is http://investor.PlantX.com
Forward
Looking-Information
This
press release contains "forward-looking information" within the
meaning of applicable securities laws. All statements contained
herein that are not clearly historical in nature may constitute
forward-looking information. In some cases, forward-looking
information can be identified by words or phrases such as "may",
"will", "expect", "likely", "should", "would", "plan",
"anticipate", "intend", "potential", "proposed", "estimate",
"believe" or the negative of these terms, or other similar words,
expressions and grammatical variations thereof, or statements that
certain events or conditions "may" or "will" happen, or by
discussions of strategy. The forward-looking information contained
herein includes, without limitation, the Company's
ability to establish further verticals and partnerships, the
benefits of Else Nutrition products, the trends and dietary habits
of consumers, the efficacy of certain vitamins and minerals, the
expected market size and growth of the baby food and formula
market, the expansion of the Company's
e-commerce
capabilities, the opening
of the Company's new
brick and
mortar locations in San Diego, CA, Squamish, B.C. and
Tel
Aviv, Israel and the business and strategic plans of the
Company.
By
their nature, forward-looking information is subject to inherent
risks and uncertainties that may be general or specific and which
give rise to the possibility that expectations, forecasts,
predictions, projections or conclusions will not prove to be
accurate, that assumptions may not be correct and that objectives,
strategic goals and priorities will not be achieved. A variety of
factors, including known and unknown risks, many of which are
beyond our control, could cause actual results to differ materially
from the forward-looking information in this press release
including, without limitation: the Company's
ability to comply with all
applicable governmental regulations including
all applicable food safety laws and regulations; impacts to the
business and operations
of the
Company due to the COVID-19 epidemic; a limited operating history,
the ability of the Company to access capital to
meet future financing needs; the Company's
reliance on management
and key personnel; competition; changes in consumer trends; foreign
currency fluctuations; and general economic, market or business
conditions.
Additional
risk factors can also be found in the Company's continuous
disclosure documents which have been filed on SEDAR and can be
accessed at
www.sedar.com.
Readers
are cautioned to consider these and other factors, uncertainties
and potential events carefully and not to put undue reliance on
forward-looking information. The forward-looking information
contained herein is made as of the date of this press release and
is based on the beliefs, estimates, expectations and opinions of
management on the date such forward-looking information is made.
The Company undertakes no obligation to update or revise any
forward-looking information, whether as a result of new
information, estimates or opinions, future events or results or
otherwise or to explain any material difference between subsequent
actual events and such forward-looking information, except as
required by applicable law.
PlantX Life (CSE:VEGA)
Historical Stock Chart
From Jul 2024 to Aug 2024
PlantX Life (CSE:VEGA)
Historical Stock Chart
From Aug 2023 to Aug 2024